Table 5.
Characteristics of patients undergoing screening stratified by age
| age <50 | age >50 | p-value | |
|---|---|---|---|
| n | 55 | 139 | |
| Gender (Male/Female) | 26/29 | 66/73 | 0.98 |
| Age (mean/SD) | 44.0/5.0 | 60.6/7.6 | <0.0001* |
| Diagnosis | |||
| Pancreatic cyst | 8 | 68 | <0.0001* |
| No cysts | 47 | 71 | |
| KRAS mutation prevalence | 38.2% | 54.0% | 0.048* |
| KRAS mutation score (mean/SD) | 1.0/2.7 | 2.2/4.2 | 0.01* |
| GNAS analysis | n=52 | n=130 | |
| GNAS mutation (Y/N) | 4/48 | 35/95 | 0.0043* |
| GNAS mutation score (mean/SD) | 0.34/1.4 | 1.82/3.90 | 0.0038* |
| KRAS/GNAS mutation | |||
| MT/MT | 1 | 15 | 0.006 * |
| MT/WT | 19 | 54 | |
| WT/MT | 3 | 20 | |
| WT/WT | 29 | 41 | |